image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Plus500 - Has returned an incredible 11.5x its IPO market value via dividends and buy-backs!

October 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PLUS
  • Price:
  • 2538p
Plus500 is an incredible animal on the London market. According to Jefferies, “No company listed in London has provided higher distributions over the past decade.” Listed in 2013 at 115p, it has generated a cumulative US$2.7bn net profit, US$3.4bn net cash and returned US$2.3bn to shareholders (11.5 times its original US$200m market cap) via US$1.5bn in dividends and US$0.8bn in share buy-backs while the shares have also gained 2100% post float. Oh and it’s just increased guidance for its full year. Plus500 is not some hot AI tech stock or the successor to Apple or Amazon or Google but it was founded in 2008 by six alumni of the Technion - Israeli Institute of Technology - with an initial investment of US$400,000.  It is an online ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe